Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2005-004391-21Phase 3Completed
Phase 3, randomised, double-blind trial in bipolar I disorder comparing Ziprasidone arm with Olanzapine arm (2 arms). Primary endpoint: Primary efficacy endpoint. Started Apr 2006; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2005-004391-21.